Seeking Alpha

MEI Pharma's Pracinostat gets orphan drug status from FDA

  • CEO Daniel Gold: "We are very pleased to receive this orphan drug designation ... AML is a particularly devastating cancer for which there are currently few broadly effective treatments. Through development of Pracinostat, we hope to address this significant unmet medical need."
  • No trades premarket, but MEIP gained 23.8% last night in AH action.
  • Press release
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|